187 related articles for article (PubMed ID: 7820956)
1. Overexpression and localization of cathepsin B during the progression of human gliomas.
Sivaparvathi M; Sawaya R; Wang SW; Rayford A; Yamamoto M; Liotta LA; Nicolson GL; Rao JS
Clin Exp Metastasis; 1995 Jan; 13(1):49-56. PubMed ID: 7820956
[TBL] [Abstract][Full Text] [Related]
2. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.
Sivaparvathi M; Yamamoto M; Nicolson GL; Gokaslan ZL; Fuller GN; Liotta LA; Sawaya R; Rao JS
Clin Exp Metastasis; 1996 Jan; 14(1):27-34. PubMed ID: 8521613
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of cathepsin B in human glioblastoma cell lines.
Konduri S; Lakka SS; Tasiou A; Yanamandra N; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Int J Oncol; 2001 Sep; 19(3):519-24. PubMed ID: 11494030
[TBL] [Abstract][Full Text] [Related]
4. Expression and the role of cathepsin H in human glioma progression and invasion.
Sivaparvathi M; Sawaya R; Gokaslan ZL; Chintala SK; Rao JS
Cancer Lett; 1996 Jun; 104(1):121-6. PubMed ID: 8640738
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
Rao JS; Yamamoto M; Mohaman S; Gokaslan ZL; Fuller GN; Stetler-Stevenson WG; Rao VH; Liotta LA; Nicolson GL; Sawaya RE
Clin Exp Metastasis; 1996 Jan; 14(1):12-8. PubMed ID: 8521611
[TBL] [Abstract][Full Text] [Related]
6. Expression of cathepsin D during the progression of human gliomas.
Sivaparvathi M; Sawaya R; Chintala SK; Go Y; Gokaslan ZL; Rao JS
Neurosci Lett; 1996 Apr; 208(3):171-4. PubMed ID: 8733297
[TBL] [Abstract][Full Text] [Related]
7. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
Mai J; Sameni M; Mikkelsen T; Sloane BF
Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
[TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
[TBL] [Abstract][Full Text] [Related]
9. Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.
Wang M; Tang J; Liu S; Yoshida D; Teramoto A
J Neurooncol; 2005 Jan; 71(1):3-7. PubMed ID: 15719267
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B expression and localization in glioma progression and invasion.
Rempel SA; Rosenblum ML; Mikkelsen T; Yan PS; Ellis KD; Golembieski WA; Sameni M; Rozhin J; Ziegler G; Sloane BF
Cancer Res; 1994 Dec; 54(23):6027-31. PubMed ID: 7954439
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
12. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
[TBL] [Abstract][Full Text] [Related]
13. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
15. Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.
Mohanam S; Wang SW; Rayford A; Yamamoto M; Sawaya R; Nakajima M; Liotta LA; Nicolson GL; Stetler-Stevenson WG; Rao JS
Clin Exp Metastasis; 1995 Jan; 13(1):57-62. PubMed ID: 7820957
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.
Sawaya RE; Yamamoto M; Gokaslan ZL; Wang SW; Mohanam S; Fuller GN; McCutcheon IE; Stetler-Stevenson WG; Nicolson GL; Rao JS
Clin Exp Metastasis; 1996 Jan; 14(1):35-42. PubMed ID: 8521615
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas.
Lucio-Eterovic AK; Cortez MA; Valera ET; Motta FJ; Queiroz RG; Machado HR; Carlotti CG; Neder L; Scrideli CA; Tone LG
BMC Cancer; 2008 Aug; 8():243. PubMed ID: 18713462
[TBL] [Abstract][Full Text] [Related]
18. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
Colin C; Voutsinos-Porche B; Nanni I; Fina F; Metellus P; Intagliata D; Baeza N; Bouvier C; Delfino C; Loundou A; Chinot O; Lah T; Kos J; Martin PM; Ouafik L; Figarella-Branger D
Acta Neuropathol; 2009 Dec; 118(6):745-54. PubMed ID: 19774387
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
Hur JH; Park MJ; Park IC; Yi DH; Rhee CH; Hong SI; Lee SH
J Korean Med Sci; 2000 Jun; 15(3):309-14. PubMed ID: 10895974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
